首頁 > 市場調查報告書 > 醫療設備

市場調查報告書

商品編碼

1736709

全球動態療法市場按產品類型、光源、應用、最終用戶、區域範圍分類，預測至 2025 年

Global Photodynamic Therapy Market By Product Type, Light Source (Lasers, Light Emitting Diodes, Lamps), Application (Cancer, Actinic Keratosis, Psoriasis, Acne), End-User, By Geographic Scope and Forecast

出版日期: 2025年05月07日 | 出版商:

Verified Market Research | 英文 202 Pages | 商品交期: 2-3個工作天內

價格

簡介目錄

動態療法市場規模及預測

2024 年光動態療法市場規模價值為 48.1 億美元，預計到 2032 年將達到 74 億美元，2026 年至 2032 年的複合年成長率為 6.10%。

動態療法 (PDT) 是一種利用光敏劑來標靶並摧毀異常或惡性細胞的醫療手段。此療法需要注入一種在目標細胞中積聚的光敏劑。當光敏劑暴露於特定波長的光下時，會發生反應產生氧氣，從而殺死目標細胞。

動態療法 (PDT) 是一種利用光敏藥物（稱為光敏劑）和特定波長的光來靶向並摧毀異常或惡性細胞的治療方法。光敏劑在光照下會發生反應，釋放一種氧，進而損害目標細胞。 PDT 常用於治療某些癌症、皮膚病和眼科疾病。

動態療法的應用範圍可能遠不止於治療癌症和皮膚病。 PDT 技術的進步有望提高其在治療更多惡性腫瘤方面的療效，尤其是那些難以觸及的部位。 PDT 在治療細菌和病毒感染等感染疾病的潛力以及在再生醫學中的應用也正在研究中。

動態療法的全球市場動態

影響全球動態療法市場的關鍵市場動態是：

關鍵市場促進因素

技術進步：技術進步是光動力治療 (PDT) 市場的關鍵驅動力。光敏劑研發、光傳輸方法和成像技術的進步顯著提高了動態療法的療效和安全性。新型光敏劑具有更高的特異性和更少的副作用，能夠更精準地靶向癌細胞和其他病變組織。雷射和 LED 等光源的改進以及成像技術的進步，使得治療的監測和控制更加便捷，最終改善了治療效果。

癌症和其他疾病的發生率不斷上升：癌症和其他慢性疾病的發生率不斷上升是光動力治療 (PDT) 市場的主要驅動力。隨著全球癌症發生率的上升，對更優治療方案的需求也不斷成長。 PDT 的副作用可能比標準療法更少，使其成為癌症治療中相當吸引人的選擇。

認知度和接受度的提升：醫療保健專業人員和患者對光動力治療 (PDT) 的認知度和接受度的提升是市場成長的關鍵驅動力。隨著越來越多的科學證據證明 PDT 的有效性和安全性，越來越多的醫療保健專業人員將 PDT 納入其治療策略。患者也越來越了解 PDT 的優勢，例如微創治療和更快的恢復時間。

主要問題

高成本和可近性：最大的問題之一是光動力治療（PDT）及其相關設備的成本高昂。光敏劑和專用光傳輸系統的研發和生產成本高昂，導致病患負擔高昂。這種高成本可能會限制治療的可近性，尤其對於貧窮國家和醫保不足的患者。

臨床應用和療效有限：儘管光動力治療（PDT）在某些惡性腫瘤和皮膚病的治療中顯示出良好的前景，但其實際應用仍然有限。 PDT的療效取決於疾病的類型和分期、所使用的光敏劑以及給藥方式。針對深層腫瘤和光滲透性較差的複雜情況，最佳化PDT治療方案面臨更多挑戰。

監管和核准障礙：應對光動力治療 (PDT) 的監管環境並非易事，因為各國對新療法和技術的核准要求各不相同。冗長而繁瑣的監管程序阻礙了創新光動力治療 (PDT) 產品和療法的推廣。此外，獲得監管批准通常需要進行大量的臨床試驗，並證明 PDT 的安全性和有效性，這既耗時又耗資。

主要趨勢

技術進步：技術進步正在動態療法市場產生重大影響。光敏劑（PDT 必不可少）的進步正在提高治療效果並減少副作用。此外，雷射和 LED 技術等光傳輸系統的進步正在提高光穿透的精度和深度，從而增強 PDT 對各種腫瘤和病變的療效。

治療應用不斷擴展：光動力治療 (PDT) 的治療範圍不斷擴大，推動了市場的成長。 PDT 傳統上用於治療癌症和皮膚病，如今也應用於眼科，治療老齡化黃斑部病變和其他眼科疾病。

更重視聯合治療：動態療法與其他療法的聯合應用日益成為趨勢，旨在增強整體治療效果。目前，人們正在研究將光動力療法 (PDT) 與化療、放射線治療和免疫療法聯合應用，以提高療效、降低抗藥性並更好地靶向腫瘤。這些聯合療法旨在克服光動力療法 (PDT) 單獨應用的局限性，從而提高其在臨床實踐中的應用率和適用性。

動態療法市場區域分析

對全球動態療法市場進行了更詳細的區域分析。

北美洲

北美在動態療法 (PDT) 市場佔據主導地位，這得益於一系列關鍵因素，包括先進的醫療基礎設施、大量的研發投入以及對突破性醫療技術的廣泛接受。尤其是美國，擁有許多推動 PDT 創新的關鍵製藥和生技公司。這些公司參與了關鍵臨床試驗和新型 PDT 產品的開發，為 PDT 技術的進步和商業化做出了貢獻。

此外，北美健全的法律規範也有利於新型光動力治療 (PDT) 療法的開發和核准。包括美國食品藥物管理局(FDA) 在內的北美監管機構確保PDT療法符合嚴格的安全性和有效性標準，為核准和商業化提供了強力的架構。此類監管支持，加上對醫療基礎設施和研究的大量投資，營造了有利於PDT在該地區擴張和主導的良好氛圍。

亞太地區

亞太地區是動態療法 (PDT) 產業成長最快的地區。中國、印度和日本等國家經濟的快速擴張和醫療支出的不斷成長，推動了市場的成長。該地區的醫療基礎設施和技術正在不斷改善，這促進了 PDT 等新型治療方式的推廣。此外，癌症和皮膚病等慢性疾病的發生率不斷上升，也推動了對新型治療方式的需求。

此外，亞太市場憑藉其龐大且多樣化的患者群體，為光動力治療（PDT）的應用提供了廣闊的前景。該地區也見證了旨在擴大PDT應用範圍並改善治療效果的臨床試驗和研究計劃的增加。隨著醫療保健相關人員和患者逐漸意識到PDT的益處及其在治療各種疾病方面的潛力，預計該市場將迅速擴張。

Photodynamic therapy (PDT) is a medical procedure that employs light-sensitive medicines known as photosensitizers to target and destroy aberrant or malignant cells. The therapy entails delivering a photosensitizer which accumulates in target cells. When exposed to a specific wavelength of light, the photosensitizer reacts and produces a type of oxygen that kills the target cells.

Photodynamic therapy (PDT) is a medical treatment that employs light-sensitive medicines known as photosensitizers and a specific wavelength of light to target and destroy aberrant or malignant cells. When exposed to light, the photosensitizer reacts and emits a type of oxygen that harms the target cells. PDT is commonly used to treat certain cancers, skin problems, and eye disorders.

Photodynamic treatment (PDT) will be used in more ways than just treating cancer and dermatological diseases. Advances in PDT are projected to increase its efficacy in treating a broader range of malignancies, particularly those in hard-to-reach regions. PDT's potential for treating infectious disorders such as bacterial and viral infections is also being investigated as is its application in regenerative medicine.

Global Photodynamic Therapy Market Dynamics

The key market dynamics that are shaping the global photodynamic therapy market include:

Key Market Drivers:

Technological Advancements: Technological advancements are a significant driver of the PDT market. Advances in photosensitizer creation, light delivery methods, and imaging techniques have considerably enhanced the effectiveness and safety of photodynamic therapy. Newer photosensitizers with increased specificity and fewer side effects are being developed enabling more precise targeting of cancer cells and other diseased tissues. Improvements in light sources such as lasers and LEDs as well as the incorporation of improved imaging techniques allow for better therapy monitoring and control, ultimately improving treatment outcomes.

Increasing Prevalence of Cancer and Other Diseases: The increased frequency of cancer and other chronic diseases is a major driver of the PDT market. As cancer rates rise worldwide, there is an increased desire for better therapeutic options. PDT provides a minimally intrusive technique with the potential for fewer adverse effects than standard therapies making it an appealing choice for cancer treatment.

Growing Awareness and Acceptance: Increased knowledge and acceptance of PDT among healthcare professionals and patients are critical market growth drivers. As scientific evidence for the efficacy and safety of PDT grows, more healthcare practitioners are adopting it into their treatment strategies. Patient knowledge of the advantages of PDT such as its minimally invasive nature and shorter recovery times is also growing.

Key Challenges:

High Costs and Accessibility: One of the most significant issues is the high cost of PDT treatments and related equipment. The research and manufacturing of photosensitizers and specialized light delivery systems can be costly resulting in significant treatment expenses for patients. This high cost may limit accessibility, particularly in poorer countries or for patients without adequate insurance coverage.

Limited Clinical Applications and Efficacy: PDT has shown promise in the treatment of certain malignancies and dermatological diseases but its practical uses remain limited. PDT's effectiveness varies according to the type and stage of the disease, the photosensitizer utilized, and the manner of delivery. Optimizing PDT for deep-seated tumors or complex circumstances with low light penetration presents additional hurdles.

Regulatory and Approval Hurdles: Navigating the regulatory landscape for PDT can be difficult because different nations have varied requirements for the approval of new therapies and technology. The lengthy and difficult regulatory procedure can cause delays in the introduction of innovative PDT goods and therapies. Furthermore, obtaining regulatory permission frequently necessitates significant clinical trials and proof confirming the safety and efficacy of PDT which can be time-consuming and expensive.

Key Trends:

Advancements in Technology: Technological advancements are greatly influencing the photodynamic therapy market. Photosensitizer advancements which are critical for PDT are improving therapy efficacy and lowering adverse effects. Furthermore, advances in light delivery systems such as laser and LED technologies are increasing the precision and depth of light penetration making PDT more effective for a variety of tumors and lesions.

Expanding Therapeutic Applications: The range of disorders treated with PDT is expanding which contributes to market growth. While PDT has traditionally been used for cancer and dermatological illnesses it is also being used in ophthalmology to treat age-related macular degeneration and other eye disorders.

Increasing Focus on Combination Therapies: There is a growing trend of combining photodynamic therapy with other treatment modalities to improve overall therapeutic results. PDT is being studied in combination with chemotherapy, radiation, and immunotherapy to improve efficacy, reduce resistance, and better target tumors. These combined approaches aim to overcome PDT's limitations when used alone, hence increasing its adoption and applicability in clinical practice.

Photodynamic Therapy Market Regional Analysis

Here is a more detailed regional analysis of the global photodynamic therapy market:

North America:

North America dominates the photodynamic treatment (PDT) market due to many major factors including advanced healthcare infrastructure, significant investment in R&D, and widespread acceptance of breakthrough medical technologies. Numerous significant pharmaceutical and biotechnology organizations, particularly in the United States, drive PDT innovation. These firms are involved in significant clinical trials and the development of new PDT products which help to advance and commercialize PDT technologies.

Furthermore, North America's robust regulatory framework promotes the development and approval of novel PDT therapies. The United States Food and Drug Administration (FDA) and other North American regulatory authorities provide a strong framework for approving and commercializing PDT treatments ensuring that they fulfill high safety and efficacy criteria. This regulatory support, combined with large investments in healthcare infrastructure and research creates an atmosphere that supports PDT's expansion and supremacy in the region.

Asia Pacific:

Asia Pacific is the fastest-growing area in the photodynamic treatment (PDT) industry owing to several factors. Rapid economic expansion and increased healthcare spending in nations such as China, India, and Japan are propelling market growth. The region is seeing an increase in healthcare infrastructure and technology improvements making it easier to embrace novel therapies such as PDT. Furthermore, the rising prevalence of chronic diseases such as cancer and dermatological problems drives the need for new treatment alternatives.

Furthermore, the Asia Pacific market has a vast and diversified patient population, providing great prospects for PDT adoption. The region is also seeing an increase in clinical trials and research projects aimed at broadening PDT uses and enhancing treatment outcomes. As healthcare practitioners and patients become more aware of PDT's benefits and potential to treat a variety of medical ailments, the market is likely to expand rapidly.

Global Photodynamic Therapy Market: Segmentation Analysis

The Global Photodynamic Therapy Market is segmented based on Product Type, Light Source, End-User, Application, and Geography.

Photodynamic Therapy Market, By Product Type

Photosensitizer Drugs
Photodynamic Therapy Devices

Based on the Product Type, the Photodynamic Therapy Market is bifurcated into Photosensitizer Drugs and photodynamic Therapy Devices. Photosensitizer drugs are more dominant in the photodynamic therapy (PDT) market. They are crucial for the effectiveness of PDT, as they are the compounds activated by light to produce a therapeutic effect. The development and commercialization of new photosensitizers drive market growth by expanding treatment options and improving efficacy and safety.

Photodynamic Therapy Market, By Light Source

Lasers
Light Emitting Diodes (LEDs)
Lamps
Others

Based on the Light Source, the Photodynamic Therapy Market is bifurcated into Lasers, Light Emitting Diodes (LEDs), Lamps, and others. Lasers are the most dominant technology in the photodynamic therapy (PDT) market. They provide precise, controlled light delivery, essential for targeting specific areas with accuracy. Lasers offer superior depth penetration and intensity modulation which is critical for effective PDT treatment, especially in oncology and dermatology. Their ability to focus light precisely on the affected area enhances treatment efficacy and minimizes damage to surrounding healthy tissue.

Photodynamic Therapy Market, By End-User

Hospitals
Cancer Treatment Centers
Cosmetic and Dermatology Clinics
Others

Based on the End-User, the Photodynamic Therapy Market is bifurcated into Hospitals, Cancer Treatment Centers, Cosmetic & Dermatology Clinics, and others. Cancer treatment centers are the most dominant in the Photodynamic Therapy (PDT) Market. These centers are key players due to the high prevalence of cancers that PDT effectively targets such as skin and certain head and neck cancers. PDT's role in providing localized treatment with minimal invasiveness aligns well with the specialized needs of cancer treatment centers. The center's focus on advanced and comprehensive cancer therapies drives significant demand for PDT supporting its growth and integration into its therapeutic offerings.

Photodynamic Therapy Market, By Application

Cancer
Actinic Keratosis (AK)
Psoriasis
Acne
Others

Based on the Application, the Photodynamic Therapy Market is bifurcated into Cancer, Actinic Keratosis (AK), Psoriasis, Acne, and others. Cancer is the most dominant application in the photodynamic therapy (PDT) market. This dominance stems from PDT's effectiveness in treating various types of cancers including skin, lung, and esophageal cancers. The ability of PDT to selectively target and destroy cancer cells with minimal damage to surrounding tissues makes it a valuable treatment option. Additionally, ongoing research and clinical trials continue to expand PDT's applications in oncology driving significant investment and interest in this area.

Photodynamic Therapy Market, By Geography

North America
Europe
Asia Pacific
Middle East and Africa
Rest of the world

Based on Geography, the Photodynamic Therapy Market is classified into North America, Europe, Asia Pacific, Middle East and Africa, and the Rest of the world. North America is the most dominant region in the photodynamic therapy market. This dominance is attributed to its advanced healthcare infrastructure, high level of research and development, and strong presence of leading medical technology companies. The region benefits from substantial investments in innovative treatments and has a high adoption rate of new therapies due to its well-established healthcare systems. Additionally, North America's significant clinical trial activity and regulatory support for new PDT technologies contribute to its leadership in the market.

Key Players

The "Photodynamic Therapy Market" study report will provide valuable insight with an emphasis on the global market. The major players in the market are Theralase Technologies Inc., Biofrontera AG, Hologic, Inc., Bausch Health, Quest PharmaTech Inc., LUMIBIRD, Galderma Laboratories L.P., Modulight, Inc., Sun Pharmaceutical Industries Ltd., and SUS Advancing Technology Co., Ltd.

Our market analysis also entails a section solely dedicated to such major players wherein our analysts provide an insight into the financial statements of all the major players, along with product benchmarking and SWOT analysis. The competitive landscape section also includes key development strategies, market share, and market ranking analysis of the above-mentioned players globally.

Global Photodynamic Therapy Market Key Developments

In January 2023, Biofrontera AG, an international biopharmaceutical company, announced that its wholly-owned subsidiary Biofrontera Bioscience GmbH received a notice of allowance from the USPTO for the application "Photodynamic therapy comprising two light exposures at different wavelengths".
In October 2022, Professor Xiuli Wang, Shanghai Skin Disease Hospital, Tongji University School of Medicine (China), has been selected as the recipient of the 2022 Clinical PDT Research Excellence Award, by the International Photodynamic Association (IPA). The Clinical PDT Research Excellence Award honors Professor Wang's substantial career achievements, which significantly accelerated the uptake of photodynamic treatment in China.

1 INTRODUCTION OF GLOBAL PHOTODYNAMIC THERAPY MARKET

1.1 Overview of the Market
1.2 Scope of Report
1.3 Assumptions

2 EXECUTIVE SUMMARY

3 RESEARCH METHODOLOGY OF VERIFIED MARKET RESEARCH

3.1 Data Mining
3.2 Validation
3.3 Primary Interviews
3.4 List of Data Sources

4 GLOBAL PHOTODYNAMIC THERAPY MARKET OUTLOOK

4.1 Overview
4.2 Market Dynamics
- 4.2.1 Drivers
- 4.2.2 Restraints
- 4.2.3 Opportunities
4.3 Porters Five Force Model
4.4 Value Chain Analysis

5 GLOBAL PHOTODYNAMIC THERAPY MARKET, BY PRODUCT

5.1 Overview
5.2 Photodynamic Therapy Devices
5.3 Photosensitizer Drug

6 Photodynamic Therapy Market, By Light Source

6.1 Overview
6.2 Lasers
6.3 Light Emitting Diodes (LEDs)
6.4 Lamps
6.5 Others

7 GLOBAL PHOTODYNAMIC THERAPY MARKET, BY APPLICATION

7.1 Overview
7.2 Cancer
7.3 Actinic Keratosis
7.4 Acne
7.5 Psoriasis
7.7 Others

8 GLOBAL PHOTODYNAMIC THERAPY MARKET, BY END-USER

8.1 Overview
8.2 Hospital
8.3 Cosmetic and Dermatology Clinics
8.4 Cancer Treatment Centers
8.5 Others

9 GLOBAL PHOTODYNAMIC THERAPY MARKET, BY GEOGRAPHY

9.1 Overview
9.2 North America
- 9.2.1 U.S.
- 9.2.2 Canada
- 9.2.3 Mexico
9.3 Europe
- 9.3.1 Germany
- 9.3.2 U.K.
- 9.3.3 France
- 9.3.4 Rest of Europe
9.4 Asia Pacific
- 9.4.1 China
- 9.4.2 Japan
- 9.4.3 India
- 9.4.4 Rest of Asia Pacific
9.5 Rest of the World
- 9.5.1 Middle East and Africa
- 9.5.2 South America

10 GLOBAL PHOTODYNAMIC THERAPY MARKET COMPETITIVE LANDSCAPE

10.1 Overview
10.2 Company Market Ranking
10.3 Key Development Strategies

11 COMPANY PROFILES

11.1 Sun Pharmaceutical Industries Ltd.
- 11.1.1 Overview
- 11.1.2 Financial Performance
- 11.1.3 Product Outlook
- 11.1.4 Key Developments
11.2 Galderma Laboratories L.P.
- 11.2.1 Overview
- 11.2.2 Financial Performance
- 11.2.3 Product Outlook
- 11.2.4 Key Developments
11.3 Biofrontera AG
- 11.3.1 Overview
- 11.3.2 Financial Performance
- 11.3.3 Product Outlook
- 11.3.4 Key Developments
11.4 LUMIBIRD
- 11.4.1 Overview
- 11.4.2 Financial Performance
- 11.4.3 Product Outlook
- 11.4.4 Key Developments
11.5 Bausch Health
- 11.5.1 Overview
- 11.5.2 Financial Performance
- 11.5.3 Product Outlook
- 11.5.4 Key Developments
11.6 Theralase Technologies Inc.
- 11.6.1 Overview
- 11.6.2 Financial Performance
- 11.6.3 Product Outlook
- 11.6.4 Key Developments
11.7 Modulight, Inc.
- 11.7.1 Overview
- 11.7.2 Financial Performance
- 11.7.3 Product Outlook
- 11.7.4 Key Developments
11.8 Hologic, Inc.
- 11.8.1 Overview
- 11.8.2 Financial Performance
- 11.8.3 Product Outlook
- 11.8.4 Key Developments
11.9 Quest PharmaTech Inc.
- 11.9.1 Overview
- 11.9.2 Financial Performance
- 11.9.3 Product Outlook
- 11.9.4 Key Developments
11.11 SUS Advancing Technology Co., Ltd.
- 11.11.1 Overview
- 11.11.2 Financial Performance
- 11.11.3 Product Outlook
- 11.11.4 Key Developments